Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

NCT00991029 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4881

Enrollment

OTHER

Sponsor class

Stopped The trial was halted by the DSMB.

Conditions

Ischemic Attack, Transient

Interventions

DRUG: Clopidogrel
DRUG: placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]